We are live on
!
Find out more
Oragenics
OGEN
OGEN
14 hedge funds and large institutions have $6.46M invested in Oragenics in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
160% more capital invested
Capital invested by funds: $2.48M → $6.46M (+$3.98M)
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
27% more funds holding
Funds holding: 11 → 14 (+3)
0.01% more ownership
Funds ownership: 0.01% → 0.01% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.3%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
6
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$2.96M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$2.61M |
| 3 |
HCS
Harvest Capital Strategies
San Francisco,
California
|
+$1.17M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$447K |
| 5 |
Barclays
London,
United Kingdom
|
+$34.6K |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$110K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$11K |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
-$3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1K |
